APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report – QNT Press Release




SYDNEY, Sept 2, 2022 – (ACN Newswire) – Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled “Evolution of Clinical Trials in the Asia Pacific Region”. The report was prepared by GlobalData and confirms that “the Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from 2017 to 2021, accounting for more than 50% of conducted trials during the analysis period.”

Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5

In addition, the GlobalData research found that all phases of clinical trials in the region registered higher growth than both the US and the EU5.

The region registered significantly higher growth than the US and the EU5 across all analysed therapeutic areas, including CNS diseases, cardiovascular diseases, gastrointestinal diseases, and infectious diseases, the latter of which the highest growth. There was witnessed also 100% growth in oncology trials during the same period.

GlobalData analysis of this strong growth has…

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center